Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Ozempic: Weight Loss Drug May Help With Addiction Too
These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.
What the End of a Tirzepatide Shortage Would Mean for Access to Compounded Weight Loss Drugs
In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its shortage list. Here's what taking the drug of the list could mean for people taking tirzepatide or its compounded versions.
Are Compounded Weight Loss Drugs on Their Way Out?
The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and Zepbound.
Popular weight-loss drugs like Ozempic could treat opioid overdose and alcohol intoxication
A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in people with opioid and alcohol use disorders.
Can Weight Loss Drugs Also Treat Addiction?
GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and alcohol intoxication, a large real-world study suggested.
Your employer may start covering weight-loss drugs soon
Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, according to a national survey conducted this year by Mercer, a human resources consulting firm.
Companies are more willing to consider covering weight-loss drugs
That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a growing number say they’re open to covering GLP-1 drugs, they’re still in the minority. Some 62% of the firms surveyed said they are “not likely” to begin coverage in the coming year.
Can Ozempic help drug addicts, too? A mega new study suggests it might.
Weight-loss and diabetes drugs like Ozempic and Mounjaro could be used to treat drug and alcohol addiction in the future — according to the first large-scale study — but more research is needed.
Weight loss drugs may help lower overdoses, alcoholism: Study
Researchers analyzed 1.3 million health records and found Ozempic, Mounjaro could lower rates of drug and alcohol overdoses.
Ozempic could be dished out to help curb boozing and prescription drug addiction
Semaglutide and tirzepatides, the active ingredients in drugs including Mounjaro and Ozempic, have been hailed as a breakthrough in the war on obesity.
8d
Washingtonians share how they afford pricey weight loss medications
Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...
UPI
10d
Health plans at 1 in 5 large companies cover weight-loss drugs for employees
When it comes to coverage for the pricey GLP-1
weight-loss
drugs
Wegovy and Zepbound, only a fifth of large U.S.
NBC 6 South Florida
9d
Surging demand leaves many without crucial diabetes and ADHD medications
The sudden surge in popularity of
drugs
like Ozempic, driven in part by its
weight loss
benefits, is contributing to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Reaches tentative union deal
Judge unseals new evidence
Philip Zimbardo dies at 91
Republicans appeal ruling
La Nina could arrive soon
Frozen waffles recalled
NC breaks turnout record
Ex-MN congressman dies
Nationwide blackout in Cuba
PG&E shuts off power
2024 induction ceremony
Netanyahu's home targeted
G7 ministers back Ukraine
NK sending troops to RU?
To furlough 700 workers
Opioid suits settlement deal
At decade-high level
$4M LAPD fentanyl seizure
Antitrust ruling delayed
US deficit reaches $1.8T
Emergency abortion ruling
Challenges military listing
School shooting report
Bladder cancer drug pulled
Probes near miss in Austin
Three Americans detained
Fire prompts evacuations
OK classroom Bible suit
Feedback